114
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

The HPLC–MS/MS Method for Determination of Diosbulbin B in the Plasma of Rats Administered with Rhizoma Dioscoreae Bulbiferae Combinations: Application to Comparative Pharmacokinetic Study

, , &

References

  • Wang, J. M.; Ji, L. L.; Branford-White, C. J.; Wang, Z. Y.; Shen, K. K.; Liu, H.; Wang, Z. T. Antitumor Activity of Dioscorea bulbifera L. Rhizome in vivo. Fitoterapia 2012, 83, 388–394.
  • Yu, Z. L.; Liu, X. R.; McCulloch, M. Screening and Analysis for Components with Antitumor Activity Bulbifera. China J. Chin. Mater. Med. 2004, 25, 563–567.
  • Gao, H.; Kuroyanagi, M.; Wu, L.; Kawahara, N.; Yasuno, T.; Nakamura, Y. Antitumor-promoting Constituents from Dioscorea bulbifera L. in JB6 Mouse Epidermal Cells. Biol. Pharm. Bull. 2002, 25, 1241–1243.
  • Li, J. H.; Zhang, X. H.; Chi, H. H. Study on Anti-tumor Effect of Different Bulbifera Extracts. J. Hebei Vocational Med. Coll. 2000, 17, 5–7.
  • Chen, X. L.; Wu, S. H.; Zhao, J. B. Suppression Effect of the Bulbifera Alcohol Extract on Mice xenografts Tumor. Acad. J. Second Mil. Med. Univ. 1998, 19, 354–355.
  • Tan, X. Q.; Yuan, J. L.; Chen, H. S.; Wang, J. Y.; Wang, J. S. Study on Anti-inflammatory Components in Dioscorea bulbifera Rhizome. Acad. J. Forth Mil. Med. Univ. 2003, 24, 677–679.
  • Rao, Y. Z.; Wen, T. L.; Zhao, H. M. 2010. Study on Anti-inflammatory Effect of Methanol Extracts from Dioscorea bulbifera L. Anhui Agri. Sci. Bull. 2010, 16, 64–65.
  • Xu, Y. Z.; Bai, X. Q.; Zhou, Q. Study on Virus Inhibitory Effect of Ethanol Extract of Dioscorea bulbifera. Pharm. Bull. 1998, 23, 535–537.
  • Zhang, H. M.; Yuan, J. Y. The Progress of Diosbulbin B Research on Pharmacology and Toxicology. China Med. Her. 2009, 28, 490–492.
  • Liu, H.; Tsim, K. W.; Chou, G. X.; Wang, J. M.; Ji, L. L.; Wang, Z. T. Phenolic Compounds from the Rhizomes of Dioscorea bulbifera. Chem. Biodivers. 2011, 8, 2110–2211.
  • Liu, H.; Chou, G. X.; Wang, J. M.; Ji, L. L.; Wang, Z. T. Steroidal saponins from the Rhizomes of Dioscorea bulbifera and Their Cytotoxic Activity. Planta Med. 2011, 77, 845–848.
  • Song, F. L.; Gan, R. Y.; Zhang, Y.; Xiao, Q.; Kuang, L.; Li, H. B. Total Phenolic Contents and Antioxidant Capacities of Selected Chinese Medicinal Plants. Int. J. Mol. Sci. 2010, 11, 2362–2372.
  • Liu, H.; Chou, G. X.; Guo, Y. L.; Ji, L. L.; Wang, J. M.; Wang, Z. T. Norclerodane Diterpenoids from Rhizomes of Dioscorea bulbifera. Phytochem. 2010, 71, 1174–1180.
  • Su, Y. W.; Chen, X.; Jiang, Z. Z.; Wang, T.; Wang, C.; Zhang, Y.; Wen, J.; Xue, M.; Zhu, D.; Zhang, Y.; Su, Y. J.; Xing, T. Y.; Zhang, C. Y.; Zhang, L. Y. A Panel of Serum microRNAs as Specific Biomarkers for Diagnosis of Compound- and Herb-induced Liver Injury in Rats. PLoS One 2012, 7, 1–11.
  • Xu, Y.; Chen, C. C.; Yang, L.; Wang, J. M.; Ji, L. L.; Wang, Z. T.; Hu., Z. B. Evaluation on Hepatotoxicity Caused by Dioscorea bulbifera Based on Analysis of Bile Acids. Acta Pharm. Sin 2011, 46, 39–44.
  • Chen, Y.; Xia, Q.; Song, C.; Ming, D. P. Study on the Hepatoxicity Mechanisms of Huangyaozi (Rhizoma dioscoreae bulbiferae) on Mouse Liver by cDNA Microarray. J. Mol. Cell Biol. 2006, 39, 568–572.
  • Wang, J.; Liang, Q.; Li, J.; Liu, H.; Wang, C.; Wang, Z. Gender-related Difference in Liver Injury Induced by Dioscorea bulbifera L. Rhizome in Mice. Hum. Exp. Toxicol. 2011, 30, 1333–1341.
  • Liu, S. M.; Cui, L. R.; Yu, D. H. Protective Effect of Angelica on Hepatic Ultrastructure Injury Induced by Bulbifera. Liaoning J. Tradit. Chin. Med. 2010, 9, 1823–1824.
  • Wang, S.; Hu, Y.; Tan, W.; Wu, X.; Chen, R.; Cao, J.; Chen, M.; Wang, Y. Compatibility Art of Traditional Chinese Medicine: From the Perspective of Herb Pairs. J. Ethnopharmacol. 2012, 143, 412–423.
  • Xutian, S.; Cao, D.; Wozniak, J.; Junion, J.; Boisvert, J. Comprehension of the Unique Characteristics of Traditional Chinese Medicine. Am. J. Chin. Med. 2012, 40, 231–244.
  • Liu, S. M.; Cui, L. R.; Yu, D. H. Protective Effect of Angelica on Hepatic Ultrastructure Injury Induced by Bulbifera. Liaoning J. Tradit. Chin. Med. 2010, 9, 1823–1824.
  • Tang, Q.; Liu, S. M.; Wang, J. Z. Effect of Dioscorea bulbifera and its Combination with Angelica on grp78 and Bad Gene Expression in Rat Liver Tissue. Adverse Drug React. J. 2010, 2, 91–95.
  • Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China, Volume I. China Medical–Pharmaceutical Science and Technology Publishing House: Beijing; 2010, pp. 124–125.
  • Wu, S. L.; Tan, X. Q.; Kang, F. F.; Guo, L. J. Determination of Diosbulbin B in Dioscorea bulbifera L. by HPLC. Anhui Medi. Pharm. J. 2011, 15, 30–32.
  • Li, Y. J.; Tian, Y.; Gan, L.; Li, Y. Z.; Chen, B.; Qiao, J. Y. Determination of Diosbulbin B in Rat Plasma and Urine by LC–MS/MS and its Application in Pharmacokinetic and Urinary Excretion Studies. J. Pharm. Biomed. Anal. 2013, 77, 133–138.
  • Matuszewski, B. K.; Constanzer, M. L.; Chavez-Eng, C. M. Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC-MS/MS. Anal. Chem. 2003, 75, 3019–3030.
  • US Food and Drug Administration, FDA Guidance for Industry. Bioanalytical Method Validation. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine; 2001.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.